7 active trials 6 recruiting 3 disease areas 1 changes in 30 days
| Phase 1 | 7 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1 | ||||
| NCT07236762 | An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases | Systemic Lupus Erythematosus | Recruiting | 2026-03-04 |
| NCT07104721 | A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases | Systemic Lupus Erythematosus (SLE) | Recruiting | 2026-03-02 |
| NCT07123519 | A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases | Systemic Lupus Erythematosus (SLE) | Recruiting | 2026-03-02 |
| NCT07236801 | Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases | Systemic Lupus Erythematosus (SLE) | Recruiting | 2026-03-02 |
| NCT06978647 | A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases | Systemic Lupus Erythematosus (SLE) | Recruiting | 2025-07-14 |
| NCT06943937 | A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus | Lupus Nephritis (LN) | Recruiting | 2025-05-13 |
| NCT07453836 | Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia | Autoimmune Hemolytic Anemia | Not Yet Recruiting | 2026-03-06 |
Lupus (SLE) (6) · Scleroderma (3) · Rheumatoid Arthritis (1)